CSIMarket
 


Electrocore Inc   (ECOR)
Other Ticker:  
 
 

ECOR's Revenue Growth by Quarter and Year

Electrocore Inc 's Revenue results by quarter and year




ECOR Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1.49 0.93 0.67
III Quarter September 1.98 1.49 1.08 0.68
II Quarter June 2.16 1.27 0.75 0.62
I Quarter March 1.90 1.20 0.73 0.41
FY   6.04 5.45 3.49 2.38



ECOR Revenue third quarter 2022 Y/Y Growth Comment
Electrocore Inc achieved in the third quarter 2022, above Company average Revenue growth of 32.62% year on year, to $ 1.98 millions.

Looking into third quarter 2022 results within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue growth. While Electrocore Inc ' s Revenue rise of 32.62% ranks overall at the positon no. 898 in the third quarter 2022.




ECOR Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 60.22 % 38.81 % -
III Quarter September 32.62 % 37.96 % 58.82 % 353.33 %
II Quarter June 70.08 % 69.33 % 20.97 % 58.97 %
I Quarter March 58.33 % 64.38 % 78.05 % -
FY   - 56.16 % 46.64 % -

Financial Statements
Electrocore Inc 's third quarter 2022 Revenue $ 1.98 millions ECOR's Income Statement
Electrocore Inc 's third quarter 2021 Revenue $ 1.49 millions Quarterly ECOR's Income Statement
New: More ECOR's historic Revenue Growth >>


ECOR Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 0 % -13.89 % -1.47 %
III Quarter September -8.52 % 17.32 % 44 % 9.68 %
II Quarter June 13.68 % 5.83 % 2.74 % 51.22 %
I Quarter March 27.52 % 29.03 % 8.96 % -
FY (Year on Year)   - 56.16 % 46.64 % -




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #173
Overall #898

Revenue Y/Y Growth Statistics
High Average Low
104.1 % 26.05 % 4.8 %
(Dec 31 2019)   (Jun 30 2020)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #173
Overall #898
Revenue Y/Y Growth Statistics
High Average Low
104.1 % 26.05 % 4.8 %
(Dec 31 2019)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Electrocore Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
52.04 % 8.32 % -61.61 %
(Jun 30 2019)  


ECOR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Electrocore Inc realized drop in Revenue from the previous quarter by -8.52% to $ 1.98 millions, from $ 2.16 millions declared in the previous quarter.

Albeit periodic circumstance normally energize III. Quarter 2022 performance, it clearly could not be sufficient to salvage Electrocore Inc 's III. Quarter 2022 outcome, Kylie Morgan, an industry contributor based in Philadelphia pointed out and mentioned that average sequential Revenue growth is at 8.32% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 135 other companies have achieved higher Revenue quarter on quarter growth. While Electrocore Inc 's Revenue growth quarter on quarter, overall rank is 3010.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #136
Healthcare Sector #499
Overall #3010
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #136
Healthcare Sector #499
Overall #3010
Revenue Q/Q Growth Statistics
High Average Low
52.04 % 8.32 % -61.61 %
(Jun 30 2019)  


ECOR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Electrocore Inc disclosed drop in Revenue sequentially by -8.52% to $ 1.98 millions, from $ 2.16 millions achived a quarter before.

Those seasonal circumstance which normally energize III. Quarter 2022 results, have not salvage the III. Quarter for the Electrocore Inc , Kylie Morgan, an industry contributor based in Philadelphia wrote, she mentioned little caution for the ECOR's perspective.

Within Medical Equipment & Supplies industry 135 other companies have achieved higher Revenue quarter on quarter growth. While Electrocore Inc 's Revenue growth quarter on quarter, overall rank is 3010.


Electrocore Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 7.52 $ 7.03 $ 6.15 $ 5.45 $ 4.89
Y / Y Revenue Growth (TTM) 53.88 % 56.92 % 54.98 % 55.93 % 50.77 %
Year on Year Revenue Growth Overall Ranking # 550 # 441 # 289 # 334 # 246
Seqeuential Revenue Change (TTM) 6.95 % 14.44 % 12.75 % 11.51 % 9.06 %
Seq. Revenue Growth (TTM) Overall Ranking # 898 # 395 # 207 # 482 # 975




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Electrocore Inc 's cumulative twelve months Revenue were $ 8 millions, company would post below average annual Revenue growth of 9.06% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Electrocore Inc 's Revenue growth from the 2.16% growth in Jun 30 2022.

In the Healthcare sector 112 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 441 to 550.

Revenue TTM Q/Q Growth Statistics
High Average Low
104.1 %
26.05 %
4.8 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 41
Healthcare Sector # 113
Overall # 550

Revenue TTM Y/Y Growth Statistics
High Average Low
562.71 %
137.01 %
46.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 41
Sector # 173
S&P 500 # 898
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Electrocore Inc 's cumulative twelve months Revenue were $ 8 millions, company would post below average annual Revenue growth of 46.1% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Electrocore Inc 's Revenue growth from the 2.16% growth in Jun 30 2022.

In the Healthcare sector 112 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 441 to 550.

Revenue TTM Q/Q Growth Statistics
High Average Low
104.1 %
26.05 %
4.8 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 41
Healthcare Sector # 113
Overall # 550

Revenue TTM Y/Y Growth Statistics
High Average Low
562.71 %
137.01 %
46.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 41
Sector # 173
S&P 500 # 898




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ECOR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ECOR's Competitors
Revenue Growth for Electrocore Inc 's Suppliers
Revenue Growth for ECOR's Customers

You may also want to know
ECOR's Annual Growth Rates ECOR's Profitability Ratios ECOR's Asset Turnover Ratio ECOR's Dividend Growth
ECOR's Roe ECOR's Valuation Ratios ECOR's Financial Strength Ratios ECOR's Dividend Payout Ratio
ECOR's Roa ECOR's Inventory Turnover Ratio ECOR's Growth Rates ECOR's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Dbv Technologies S a 56.76%$ 56.765 millions
Ptc Therapeutics inc 56.50%$ 56.496 millions
Janux Therapeutics Inc 56.43%$ 56.428 millions
Dynavax Technologies Corporation56.37%$ 56.367 millions
Bionano Genomics Inc 55.12%$ 55.124 millions
Deciphera Pharmaceuticals Inc 54.93%$ 54.927 millions
Absci Corp53.93%$ 53.931 millions
Agilon Health Inc 51.51%$ 51.513 millions
Silk Road Medical Inc 51.31%$ 51.306 millions
Twist Bioscience Corporation51.01%$ 51.007 millions
Caremax Inc 50.71%$ 50.707 millions
Axonics Inc 50.03%$ 50.031 millions
F star Therapeutics Inc 49.80%$ 49.800 millions
Mannkind Corporation47.79%$ 47.787 millions
Revance Therapeutics Inc 46.95%$ 46.949 millions
Kempharm Inc46.26%$ 46.260 millions
Predictive Oncology Inc 45.32%$ 45.324 millions
Harmony Biosciences Holdings inc 45.18%$ 45.179 millions
Insmed Inc44.86%$ 44.855 millions
Seaspine Holdings Corporation44.57%$ 44.573 millions
Tela Bio Inc 44.55%$ 44.552 millions
Sorrento Therapeutics Inc 44.25%$ 44.255 millions
Luna Innovations Inc43.41%$ 43.406 millions
Alphatec Holdings Inc 42.87%$ 42.874 millions
Sight Sciences Inc 42.56%$ 42.562 millions
Urogen Pharma Ltd 41.81%$ 41.811 millions
Cumberland Pharmaceuticals Inc 41.38%$ 41.381 millions
Alnylam Pharmaceuticals Inc 40.86%$ 40.863 millions
Endonovo Therapeutics Inc 40.69%$ 40.693 millions
Oak Street Health Inc 40.39%$ 40.391 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CATO's Profile

Stock Price

CATO's Financials

Business Description

Fundamentals

Charts & Quotes

CATO's News

Suppliers

CATO's Competitors

Customers & Markets

Economic Indicators

CATO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071